ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway

Despite advancements in therapeutic options, the overall prognosis for non-small cell lung cancer (NSCLC) remains poor. Therefore, it is crucial to further explore the etiology and targets for novel treatments to effectively manage NSCLC. In this study, immunohistochemistry was used to analyze the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Bin, Lu, Fengjuan, Jiang, Shujuan, Xing, Mengmeng, Mao, Xinyu, Yang, Guanghai, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564444/
https://www.ncbi.nlm.nih.gov/pubmed/37724906
http://dx.doi.org/10.18632/aging.205038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564444/
https://www.ncbi.nlm.nih.gov/pubmed/37724906
http://dx.doi.org/10.18632/aging.205038

Ejemplares similares